Status:
COMPLETED
Impact of Priming the Infusion System on the Performance of Target-controlled Infusion of Remifentanil
Lead Sponsor:
Ajou University School of Medicine
Conditions:
Intravenous Drug Usage
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
The investigators attempted to determine an adequate priming volume for our infusion system, and investigated the extent of a possible delay of the drug effect, that would result from mechanical defec...
Detailed Description
Priming the infusion system (PRIMING) was performed using an evacuation of 2.0 ml to the atmosphere prior to Target-controlled Infusion (TCI). Forty eight TCI, using 50 μg/ml or 20 μg/ml of remifentan...
Eligibility Criteria
Inclusion
- electric medical records of the patients who had undergone general anaesthesia
Exclusion
- body weight exceeding 20% of ideal body weight
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT01477905
Start Date
March 1 2011
End Date
April 1 2011
Last Update
November 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ajou University School of Medicine
Suwon, South Korea, 443-721